Author

A Mircea-Catarig

Institution: Novo Nordisk (Denmark)

Observed institution: Novo Nordisk (Denmark)

OpenAlex ID: A5159577574

Cardiovascular outcomes by baseline blood pressure control status in persons with type 2 diabetes at high cardiovascular risk treated with oral semaglutide

2026 · N Poulter, S L Mulvagh, et al. · European Heart Journal

Works count: 1

Citation count:

H-index:

I10-index: